Abbott Yanks Trifecta Valves From US Market

In February, Abbott and the US FDA warned that the valves could wear out faster than competing models, leading to a condition called early structural valve deterioration. Abbott has now decided to stop distributing Trifecta products within the US.

Heart made out of red puzzle pieces with one piece missing
• Source: Shutterstock

Trifecta heart valves will no longer be sold in the US, Abbott  announced in a 31 July letter to customers.

In February, the company and the US Food and Drug Administration warned providers and patients that patients treated with the...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Compliance

More from Policy & Regulation